Loading clinical trials...
Loading clinical trials...
This study seeks to evaluate whether using non-invasive electrocardiograph (ECG) techniques, including long term ECG monitoring with wearable ECGs, can improve the detection of concealed Brugada syndrome.
Application of long term continuous ECG monitoring via ECG wearables and ambulatory ECG monitors to detect manifestations of Brugada syndrome. This approach will be combined with development of an AI (artificial intelligence) enabled ECG platform to automate Brugada ECG detection and analysis. The protocol will comprise the following parts: Study A: Brugada ECG AI development. This will automate the recognition of the type 1 Brugada ECG pattern on 12 lead ECGs. Study B: Remote arrhythmia diagnostics. A prospective observational study whereby recruited participants will be fitted with a wearable ECG or cardiac monitor to undergo continuous long term ambulatory ECG monitoring. The algorithms developed in study A will be applied to long term ECG data captured in this study. Study C: Arrhythmic risk stratification using ultra-high-frequency ECG. This exploratory study will look for markers of arrhythmic risk in patients with manifest and concealed arrhythmia syndromes.
Age
18 - 100 years
Sex
ALL
Healthy Volunteers
Yes
Imperial College Healthcare NHS Trust
London, United Kingdom
Start Date
September 9, 2024
Primary Completion Date
November 1, 2026
Completion Date
November 1, 2026
Last Updated
May 23, 2025
200
ESTIMATED participants
12-lead ECG
DIAGNOSTIC_TEST
Continuous long term ambulatory ECG monitoring
DIAGNOSTIC_TEST
Ultra-high-frequency ECG
DIAGNOSTIC_TEST
Lead Sponsor
Imperial College London
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions